Publications by authors named "A L Cavalot"
Objective: To perform a cross-cultural adaptation into Italian and to analyse reliability and validity of the Transsexual Voice Questionnaire for male-to-female transsexuals (I-TVQ).
Study Design: Cross-sectional nonrandomized survey study.
Methods: For item-generation, a cross-cultural adaptation and translation process was performed following standard guidelines.
Closure of Tracheoesophageal Puncture after Total Laryngectomy.
Otolaryngol Head Neck Surg
August 2019
Tracheoesophageal puncture with voice prosthesis placement is used to restore vocal function after total laryngectomy. However, closure of the fistula is sometimes needed. At our department, a simple and effective technique for closure was developed.
View Article and Find Full Text PDFThe use of platelet-rich plasma gel in superficial parotidectomy.
Acta Otorhinolaryngol Ital
December 2019
In-clinic secondary tracheoesophageal puncture and voice prosthesis placement in laryngectomees.
Eur Ann Otorhinolaryngol Head Neck Dis
October 2018
Secondary tracheoesophageal puncture (TEP) with voice prosthesis placement represents one of the possibility to restore vocal function after total laryngectomy. However, some patients have comorbidities that contraindicate general anesthesia. In our department, an in-clinic TEP procedure for retrograde voice prosthesis placement was developed.
View Article and Find Full Text PDFArticle Synopsis
- Studies from the 1970s and 1980s indicated that bacterial lysates could help prevent recurrent respiratory tract infections (RRTI), but modern clinical trials have improved procedures for evaluation.
- A recent double-blind, placebo-controlled trial assessed Lantigen B®, a bacterial lysate, showing that patients using it experienced significantly fewer infections and reduced antibiotic usage compared to those on placebo.
- While there was no significant difference in allergic episodes between groups, patients on Lantigen B also used fewer bronchodilators and antihistamines, suggesting Lantigen B could be an effective first-line treatment to prevent infections in RRTI patients.